Published in J Hypertens on October 01, 2006
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc (2008) 1.20
Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier. Mol Med (2010) 0.98
Hypertension and cognitive function. Clin Geriatr Med (2009) 0.88
The treatment of hypertension in people with dementia: a systematic review of observational studies. BMC Geriatr (2014) 0.80
The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target. Vasc Health Risk Manag (2008) 0.79
Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden. BMC Cardiovasc Disord (2016) 0.78
A Comparison of Cognitive and Everyday Functional Performance among Older Adults With and Without Hypertension. Clin Gerontol (2013) 0.77
Effect of antihypertensive therapy on cognitive functions of patients with hypertension. Ann Indian Acad Neurol (2010) 0.75
A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients. Medicine (Baltimore) (2016) 0.75
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol (2005) 4.20
Treatment of hypertension and prevention of dementia. Alzheimers Dement (2005) 2.13
Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke (2002) 1.57
Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke (2005) 1.51
Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology. Surgery (2010) 1.48
Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature. Arthritis Rheum (2010) 1.30
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res (2012) 1.22
International Association of Gerontology and Geriatrics: a global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc (2011) 1.22
Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease. Pharmacogenetics (2002) 1.08
Cognitive stimulation intervention for elders with mild cognitive impairment compared with normal aged subjects: preliminary results. Aging Clin Exp Res (2007) 1.05
Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: relevance to oxidative stress. Atherosclerosis (2009) 1.00
Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies. Acta Cardiol (2003) 0.98
Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med (2003) 0.97
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial. J Hypertens (2006) 0.96
Patterns of hypertension management in France (ENNS 2006-2007). Eur J Prev Cardiol (2011) 0.96
Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study. J Am Geriatr Soc (2011) 0.93
Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. J Hypertens (2014) 0.92
Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial. J Hypertens (2009) 0.92
Hypertension and dementia. Curr Cardiol Rep (2003) 0.91
Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol (2008) 0.88
Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study. Clin Drug Investig (2007) 0.87
Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people. Arch Cardiovasc Dis (2013) 0.87
Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol (2013) 0.86
Expert consensus: Renal denervation for the treatment of hypertension. Diagn Interv Imaging (2012) 0.86
Older age at retirement is associated with decreased risk of dementia. Eur J Epidemiol (2014) 0.86
Patients with Alzheimer's disease living at home in France: costs and consequences of the disease. J Geriatr Psychiatry Neurol (2003) 0.84
Homocysteine is the only plasma thiol associated with carotid artery remodeling. Atherosclerosis (2002) 0.83
Prevention of dementia: lessons from SYST-EUR and PROGRESS. J Neurol Sci (2004) 0.83
Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemp Clin Trials (2007) 0.83
Expert consensus: renal denervation for the treatment of arterial hypertension. Arch Cardiovasc Dis (2012) 0.82
A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial. Drugs Aging (2006) 0.82
How to limit screening of patients for atheromatous renal artery stenosis in two-drug resistant hypertension? J Nephrol (2005) 0.82
Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. J Neurol Sci (2002) 0.82
Accuracy of the ankle-brachial index using the SCVL(®), an arm and ankle automated device with synchronized cuffs, in a population with increased cardiovascular risk. Vasc Health Risk Manag (2012) 0.81
Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Am J Hypertens (2008) 0.81
Dementia and antihypertensive treatment. Curr Opin Nephrol Hypertens (2004) 0.81
Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohort. Atherosclerosis (2013) 0.81
Prevention of dementia and cerebroprotection with antihypertensive drugs. Curr Hypertens Rep (2004) 0.80
Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study. Dement Geriatr Cogn Disord (2013) 0.80
Systolic blood pressure is depending on the arm position when home blood pressure is measured with a wrist or an arm validated monitor. Blood Press Monit (2010) 0.80
Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice. J Am Soc Hypertens (2009) 0.79
[Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension]. Presse Med (2013) 0.79
Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis. Int Psychogeriatr (2009) 0.79
[Support for patients with Alzheimer's disease and their caregivers by gerontechnology]. Geriatr Psychol Neuropsychiatr Vieil (2011) 0.78
Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3. Am J Cardiovasc Drugs (2011) 0.78
Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database. J Hypertens (2016) 0.78
Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease. J Neurol Sci (2007) 0.78
Consensus of the French Society of Gerontology and Geriatrics and the French Society of Cardiology for the management of coronary artery disease in older adults. Arch Cardiovasc Dis (2009) 0.78
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial. J Hypertens (2014) 0.78
Apolipoprotein E epsilon4 allele and clinically defined vascular depression. Arch Gen Psychiatry (2002) 0.78
The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study. J Alzheimers Dis (2013) 0.78
Association between the G protein beta3 subunit 825t allele and radial artery hypertrophy. J Vasc Res (2003) 0.77
Reduced insulin secretion and nocturnal dipping of blood pressure are associated with a disturbed circadian pattern of urine excretion in metabolic syndrome. J Clin Endocrinol Metab (2011) 0.76
A single-pill combination of amlodipine besylate and atorvastatin calcium (update). Drugs Today (Barc) (2007) 0.76
[Expert consensus of the French society of geriatrics and gerontology and the French society of cardiology on the management of atrial fibrillation in elderly people]. Geriatr Psychol Neuropsychiatr Vieil (2013) 0.76
Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics. J Hypertens (2016) 0.76
Commentary: a brief history of geriatrics. J Gerontol A Biol Sci Med Sci (2004) 0.75
Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension. Curr Med Res Opin (2012) 0.75
Cross-validation of a Shortened Battery for the Assessment of Dysexecutive Disorders in Alzheimer Disease. Alzheimer Dis Assoc Disord (2016) 0.75
Maintaining cognitive health in an ageing society. J R Soc Promot Health (2004) 0.75
[Difficulty in assessing renal function in elderly hypertensive patients. Results of a survey in the geriatric environment]. Presse Med (2002) 0.75
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial. Blood Press (2008) 0.75
Waist circumference is a strong and independent determinant of the distribution of HDL subfractions in overweight patients with cardiovascular risk factors. Diab Vasc Dis Res (2012) 0.75
[Evaluation of a workplace health promotion program]. Sante Publique (2014) 0.75
Antihypertensive drugs and cognitive function. Curr Hypertens Rep (2002) 0.75
Carotid intima-media thickness and carotid and/or iliofemoral plaques: comparison of two markers of cardiovascular risk in hypertensive patients. J Hypertens (2003) 0.75